Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

619 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Weekly infusional high-dose fluorouracil (HD-FU), HD-FU plus folinic acid (HD-FU/FA), or HD-FU/FA plus biweekly cisplatin in advanced gastric cancer: randomized phase II trial 40953 of the European Organisation for Research and Treatment of Cancer Gastrointestinal Group and the Arbeitsgemeinschaft Internistische Onkologie.
Lutz MP, Wilke H, Wagener DJ, Vanhoefer U, Jeziorski K, Hegewisch-Becker S, Balleisen L, Joossens E, Jansen RL, Debois M, Bethe U, Praet M, Wils J, Van Cutsem E; European Organisation for Research and Treatment of Cancer Gastrointestinal Group; Arbeitsgemeinschaft Internistische Onkologie. Lutz MP, et al. Among authors: wilke h. J Clin Oncol. 2007 Jun 20;25(18):2580-5. doi: 10.1200/JCO.2007.11.1666. J Clin Oncol. 2007. PMID: 17577037 Clinical Trial.
Weekly therapy with folinic acid (FA) and high-dose 5-fluorouracil (5-FU) 24-hour infusion in pretreated patients with metastatic colorectal carcinoma. A multicenter study by the Association of Medical Oncology of the German Cancer Society (AIO).
Weh HJ, Wilke HJ, Dierlamm J, Klaassen U, Siegmund R, Illiger HJ, Schalhorn A, Kreuser ED, Hilgenfeld U, Steinke B, et al. Weh HJ, et al. Among authors: wilke hj. Ann Oncol. 1994 Mar;5(3):233-7. doi: 10.1093/oxfordjournals.annonc.a058799. Ann Oncol. 1994. PMID: 8186170 Free article.
Adjuvant chemoradiation using 5-fluorouracil/folinic acid/cisplatin with or without paclitaxel and radiation in patients with completely resected high-risk gastric cancer: two cooperative phase II studies of the AIO/ARO/ACO.
Kollmannsberger C, Budach W, Stahl M, Schleucher N, Hehr T, Wilke H, Schleicher J, Vanhoefer U, Jehle EC, Oechsle K, Trarbach T, Boehlke I, Kanz L, Hartmann JT, Bokemeyer C. Kollmannsberger C, et al. Among authors: wilke h. Ann Oncol. 2005 Aug;16(8):1326-33. doi: 10.1093/annonc/mdi252. Epub 2005 May 26. Ann Oncol. 2005. PMID: 15919686 Free article. Clinical Trial.
Matuzumab plus epirubicin, cisplatin and capecitabine (ECX) compared with epirubicin, cisplatin and capecitabine alone as first-line treatment in patients with advanced oesophago-gastric cancer: a randomised, multicentre open-label phase II study.
Rao S, Starling N, Cunningham D, Sumpter K, Gilligan D, Ruhstaller T, Valladares-Ayerbes M, Wilke H, Archer C, Kurek R, Beadman C, Oates J. Rao S, et al. Among authors: wilke h. Ann Oncol. 2010 Nov;21(11):2213-2219. doi: 10.1093/annonc/mdq247. Epub 2010 May 23. Ann Oncol. 2010. PMID: 20497967 Free article. Clinical Trial.
Neoadjuvant therapy for squamous cell esophageal carcinoma.
Fink U, Stein HJ, Bochtler H, Roder JD, Wilke HJ, Siewert JR. Fink U, et al. Among authors: wilke hj. Ann Oncol. 1994;5 Suppl 3:17-26. doi: 10.1093/annonc/5.suppl_3.s17. Ann Oncol. 1994. PMID: 8204527 Review.
619 results